203
Participants
Start Date
March 23, 2018
Primary Completion Date
August 18, 2026
Study Completion Date
November 18, 2026
Experimental continuous peripheral nerve blocks
Bupivacaine 0.3% \[or ropivacaine 0.5%\] infusions for 7 days via femoral and sciatic perineural catheters
Control continuous peripheral nerve blocks
Bupivacaine 0.1% \[or ropivacaine 0.2%\] infusions for 1 day followed by normal saline for a total of 7 days via femoral and sciatic perineural catheters
Fairview Hospital, Cleveland
Cleveland Clinic, Cleveland
University of Texas MD Anderson Cancer Center, Houston
University California San Diego, San Diego
Naval Medical Center San Diego, San Diego
Mass. General Hospital, Boston
Brigham and Women's Hospital, Boston
Boston VA, Boston
United States Department of Defense
FED
United States Naval Medical Center, San Diego
FED
The Cleveland Clinic
OTHER
Walter Reed National Military Medical Center
FED
Johns Hopkins University
OTHER
Wake Forest University Health Sciences
OTHER
Boston VA
UNKNOWN
Massachusetts General Hospital
OTHER
Brigham and Women's Hospital
OTHER
University of California, San Diego
OTHER